An economic model to evaluate cost-effectiveness of computer assisted knee replacement surgery in Norway by Gøthesen, Øystein Johannes et al.
Gøthesen et al. BMC Musculoskeletal Disorders 2013, 14:202
http://www.biomedcentral.com/1471-2474/14/202RESEARCH ARTICLE Open AccessAn economic model to evaluate cost-
effectiveness of computer assisted knee
replacement surgery in Norway
Øystein Gøthesen1*, James Slover2, Leif Havelin3,4, Jan Erik Askildsen5, Henrik Malchau6 and Ove Furnes3,4Abstract
Background: The use of Computer Assisted Surgery (CAS) for knee replacements is intended to improve the
alignment of knee prostheses in order to reduce the number of revision operations. Is the cost effectiveness of
computer assisted surgery influenced by patient volume and age?
Methods: By employing a Markov model, we analysed the cost effectiveness of computer assisted surgery versus
conventional arthroplasty with respect to implant survival and operation volume in two theoretical Norwegian age
cohorts. We obtained mortality and hospital cost data over a 20-year period from Norwegian registers. We
presumed that the cost of an intervention would need to be below NOK 500,000 per QALY (Quality Adjusted Life
Year) gained, to be considered cost effective.
Results: The added cost of computer assisted surgery, provided this has no impact on implant survival, is NOK
1037 and NOK 1414 respectively for 60 and 75-year-olds per quality-adjusted life year at a volume of 25 prostheses
per year, and NOK 128 and NOK 175 respectively at a volume of 250 prostheses per year. Sensitivity analyses
showed that the 10-year implant survival in cohort 1 needs to rise from 89.8% to 90.6% at 25 prostheses per year,
and from 89.8 to 89.9% at 250 prostheses per year for computer assisted surgery to be considered cost effective. In
cohort 2, the required improvement is a rise from 95.1% to 95.4% at 25 prostheses per year, and from 95.10% to
95.14% at 250 prostheses per year.
Conclusions: The cost of using computer navigation for total knee replacements may be acceptable for 60-year-old
as well as 75-year-old patients if the technique increases the implant survival rate just marginally, and the
department has a high operation volume. A low volume department might not achieve cost-effectiveness unless
computer navigation has a more significant impact on implant survival, thus may defer the investments until such
data are available.
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Total knee replacement is considered a cost effective
surgical procedure of considerable benefit to the patient.
Patients experience a markedly improved quality of life
after this type of intervention [1]. On the other hand,
there is a risk that aseptic loosening, malalignment and
instability, patellar pain or infection, may lead to poorer
functionality and quality of life for the patient [2,3]. Over* Correspondence: oystein.gothesen@helse-fonna.no
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reproduction in any medium, provided the orthe last decade computer assisted orthopaedic surgery
has undergone development, and the use of this type of
navigation system is becoming increasingly common
(Figure 1). In 2008, 19% of all primary knee replace-
ments in Norway were computer assisted [4]. Better po-
sitioning of the prosthesis will in theory reduce the
number of revisions [5,6].
A number of randomised studies have demonstrated
better positioning of components when computer navi-
gation has been used [7]. The follow-up time for these
studies is short, and the results vary when it comes to
improved functionality [8]. So far, no-one has been ableral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Infrared rays are reflected from reflection balls
attached to the tibia and femur and back to the camera and
the computer. The reciprocal distances and movements measured
between the balls are registered by the computer which builds a
model of the extremeties axes and anatomy. Surgical instruments
are navigated according to the same principle.
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the number of revision operations. Computer navigation
equipment is expensive, and its use prolongs the oper-
ation time [7]. Hospitals have scarce resources at their
disposal and consequently it is important that the cost
effectiveness of new methods and new technology is
evaluated, to ensure that every penny is spent on achiev-
ing optimal health effects. Within the field of knee re-
placement surgery good instrumentation is already in
use, which is why we need to be extra critical whenever
new methods are introduced. History has taught us that
new technology and new methods are best introduced in
stages, before the market is let loose. This approach pro-
vides an opportunity to discover weaknesses at an early
stage, to prevent unnecessary harm to patients and the
waste of public funds [9]. The Boneloc cement case
(used to fix prostheses) which involved 20 Norwegian
hospitals from 1991–1993, is but one example demon-
strating the importance of thorough evaluation and test-
ing [10]. In theory, computer assisted surgery should
result in a better quality of life for the patient, measured
in quality-adjusted life years, by reducing the probability
of revisions. This model is supposed to guide health care
providers in their investments and implementation of
new technology. When considering an investment in
CAS, it is important to have an idea of what impact thisnew technology is required to have on patient outcome,
in order to achieve cost-efficiency for different age
groups and hospital sizes (patient volumes). From the
point of view of a healthcare enterprise, we wish to com-
pare the cost per quality-adjusted life year gained by
using computer navigation and conventional total knee
arthroplasty (TKA) respectively. We also wish to dis-
cover how age, patient volume and revision probability
influence the cost effectiveness.
Methods
Economic evaluation
The relative profitability of two alternative technologies,
computer assisted and convensional surgery, is established
using a cost effectiveness analysis. This type of comparison
needs to consider possible changes to both benefits and
costs. New technology may be cheaper or more expensive,
and may have a better or worse impact compared to trad-
itional technology. If computer assisted surgery proves to
be cheaper and better, or poorer and more expensive, the
solution is trivial, since one technology is dominant. The
need for deliberation arises if both costs and benefits
change in the same direction. This is normally presented
in the form of an incremental cost-effectiveness ratio –
ICER, i.e. an equation showing the change in cost relative
to the change in effect for the two alternatives. This pro-
vides a cost per unit of benefit gained, which in turn may
be compared to society's demand for useful employment
of resources. In Norway, common practice uses a thresh-
old value of NOK 500,000 for acceptable cost per quality-
adjusted life year gained [11]. This does not mean that
every intervention that scores below the threshold value
should necessarily be accepted. It is also necessary to con-
sider the intervention in relation to the resources available.
Consequently, it is important to clarify the perspective of
the analysis - patient, healthcare enterprise or society. Our
analysis considers the benefits and costs from the point of
view of a healthcare enterprise, while more indirect social
costs, to relatives for instance, or the cost of absence from
work, are excluded.
The measure of benefit is a quality-adjusted life year.
This means that consideration is given not only to sur-
vival, but also to the quality of the patient’s health, mea-
sured on a scale from 0 (dead) to 1 (in perfect health),
and for how long this health state lasts. There are a
number of methods for measuring quality of life. Based
on hypothetical questions about what one is willing to
sacrifice in order to go from a poor state of health to a
perfect state of health, along a number of different di-
mensions of weakened health, it is possible to arrive at a
utility value. The utility values used here have been cal-
culated by means of EQ-5D, a standardised question-
naire (developed by the EuroQol Group) which includes
the five dimensions of mobility, self-care, usual activities,
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sion has three levels – no problems, some problems, ex-
treme problems. By establishing the number of years
during which patients experience the different utility
values, we arrive at quality-adjusted life years. In turn
these can be summarised for a patient population, in
order to find the total benefit levels (measure of benefit)
to be compared against the costs.
A treatment outcome is often uncertain, and a number
of possible states may be envisaged. This means that the
costs and benefits included are uncertain values, and we
need to take account of the different treatment outcomes
by adjusting for this uncertainty. By using a Markov deci-
sion model we are able to draw up a useful and clear pres-
entation of different outcomes and their associated
probabilities.
Model
A Markov decision model is used to analyse various
matters in a number of cycles (20 years in this model).
In our model, a cycle equalled one year. We looked at
the probability of certain occurences, such as revision
and death, within each cycle. Since each occurence had
an associated probability, this probability could be used
to calculate the relevant costs and utility values within
the same cycle (Figure 2).
Costs and utility values were allocated to each primary
procedure and revision procedure. In this model, the pa-
tients went from one health state to another at an age-
specific frequency and probability based on Norwegian
data sources. The theoretical patient cohort accumulated
costs and utility values over time. All costs and utility
values accumulated over zero time were discounted atFigure 2 The Markov Model. The patient undergoes a total knee replace
conventional total knee arthroplasty (TKA). If the patient survives the opera
needs a revision. The model comprises 20 yearly cycles until all patients ha
either retain the same health state or go to a different health state. The be
years (QALYs) for each cycle and are summarised after 20 cycles.4% per year [12]. The impact of alternative assumptions
about the discount rate was tested using sensitivity ana-
lyses. Based on the Markov model, we deduced total
costs and quality-adjusted life years to evaluate the cost
effectiveness of conventional surgical techniques and
computer assisted surgery. The model was constructed
using a decision analysis software (TreeAge Pro 2009,
Williamstown, MA).
The model was based on the following premise: 1) Pa-
tients who have their total knee prosthesis implanted by
conventional surgery or by computer assisted surgery dem-
onstrate the same post-operative utility value. 2) Mortality
after the first year is the same as for other patients the
same age who have not undergone this type of operation.
3) In this model, the patients will need only a single revi-
sion operation, and they have utility values allocated for
the rest of their lives that match the value normally
achieved following a single revision. The values of the vari-
ous model parameters are given in Table 1.
Cohorts
We have undertaken an analysis of two groups of pa-
tients: 60-year-olds and 75-year-olds.
Implant survival
Stipulations were made for implant survival and yearly
probability of revision within the two cohorts based on data
from the Norwegian Arthroplasty Register for patients over
and under the age of 70 who had undergone surgery
without computer assistance. For the younger cohort (60-
year-olds) the implant survival and probability of revision
in the model were set equal to the data for patients under
the age of 70, whereas implant survival and probability ofment operation, either by computer assisted surgery (CAS) or
tion, he remains in perfect health until he dies of other causes, or
ve reached the health state of “dead”. In each cycle, the patients can
nefits of each surgical method are measured in quality-adjusted life
Table 1 Model parameters and premise
TKA CAS Revision
Parameter values obtained from the literature
Utility values
Postoperative 0.73 (30) 0.73 (30) 0.6 (3)
Preoperative 0.4 (30) 0.4 (30) 0.73
Estimated/obtained parameter values
Disutility value -0.1 -0.1 -0.2
Mortality, 1st year after operation 0,63% 0,63%
Mortality, remaining lifetime Table B Table B
Additional file Additional file
Cost (NOK) based on DRG 146.135(28) 146.135(28) 192.418(28)
Implant survival /probability of revision Table A Table A
Additional file Additional file
Number of revisions 1 1 No re-revision
Annual added cost* of computer navigation (NOK)
Alternative 1 216.500
Alternative 2 433.000
*Total added cost for computer navigation equipment, software and maintenance contract per year. The cost per patient is described in the method section and
depends on patient volume.
Gøthesen et al. BMC Musculoskeletal Disorders 2013, 14:202 Page 4 of 9
http://www.biomedcentral.com/1471-2474/14/202revision for the older cohort (75-year-olds) were set equal
to the data for patients over 70 years of age (Table D in
Additional file 1). For years 1 to 11 we used register data to
find the yearly probability of revision by means of the
Kaplan-Meier method. For years 12 to 20 we estimated the
probability of revision to match the results reported by the
Swedish knee arthroplasty register and large-scale cohort
studies [13-16]. We have used probability of revision (100%
minus implant survival ) as a concept in the model, but
since Norwegian practice traditionally gives implant sur-
vival (100-probability of revision), we calculate the corre-
sponding 10-year implant survival by making an
approximation that the probability of revision is the same
from year to year (both values are given in Table A in the
Additional file 1).
The Norwegian Arthroplasty Register was established
in 1987 by the Norwegian Orthopaedic Association; it is
publicly funded and is independent of the implant indus-
try [17,18]. The register started collecting data for con-
ventional total knee arthroplasty (TKA) in 1994 [2].
Norwegian surgeons have reported 99% of primary knee
prostheses and 97% of revisions [19].
Probability of death
The probability of death within the first year, including
perioperative death, was set to 0.63% for cohort 1 and
2.40% for cohort 2, based on linked data from the
Norwegian Arthroplasty Register and the National Regis-
ter for 60 and 75-year-olds. Probability of death after the
first year, irrespective of knee replacement surgery, was setequal to the age-specific mortality in the population [20]
(Table B in Additional file 1). Studies have shown that the
mortality rate is higher for knee replacement revision sur-
gery than for primary knee replacement surgery [21]. The
perioperative mortality was therefore set 50% higher for
revisions within this model, to 0.95% and 3.60% respect-
ively for cohorts 1 and 2.
Utility values
Patients who receive total knee replacement surgery are
expected to enjoy the same quality of life on completion of
the postoperative phase and rehabilitation period whether
their surgery was conventional or computer assisted. The
utility values that were used in the model were based on
findings from earlier publications on arthroplasty surgery
[22,23]. The pre-operative value was set to 0.40, the post-
operative value to 0.73 (the operation provides an improve-
ment of 0.33). These values are similar to those found in
the Swedish hip arthroplasty register, and match the values
found for knee replacements [24]. The values are here
based on EQ-5D, which is a commonly used instrument
for measuring quality of life. Studies have shown that the
results following revision replacement surgery is poorer
than after primary replacements [3,22]. The value following
knee replacement revision surgery was therefore set to an
initial value of 0.60.
Disutility value
The disutility value represents the disutility of the re-
duced quality of life experienced by the patient in
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come [25]. In this model, disutility values represent the
reduced quality of life a patient might experience in con-
nection with the operation. The disutility value includes
any reduced mobility, increased pain and potential com-
plications that the patient may experience in the peri-
operative phase. The value is given at the time a patient
is undergoing a procedure in the model. The disutility
values of conventional knee replacement surgery, com-
puter assisted knee replacement and the revision pros-
thesis operation, were entered into the model and
contributed to a downward adjustment of quality-
adjusted life years compared to the patient’s total value
of quality-adjusted life years. The disutility value of a
total knee replacement was set to −0.1 on a discretionary
basis and was only allocated to the first post-operative
year (i.e. a utility value of 0.73-0.1=0.63 in the model’s
first cycle). Some have pointed out the risk of increased
perioperative morbidity in connection with computer
assisted knee replacement operations due to the risk of
fracture and infection associated with the positioning of
external fixation pins in bone, as well as a longer oper-
ation time. However, the incidence of these complica-
tions is so low that we allocated the same disutility value
to computer navigation as to the conventional technique
[26,27]. Revisions, which involve a higher frequency of
complications and a longer training period than primary
knee replacements, were allocated a value of −0.2
quality-adjusted life years.
Costs
The added cost of computer navigation includes expend-
iture such as computer hardware and knee replacement
software, instruments and maintenance contracts. This
was estimated at NOK 1,082,500 per department per
year. Disposable equipment (reflection balls) constituted
an additional cost, set to NOK 200 per operation. The
costs are based on prices obtained from Brainlab Scandi-
navia, which is a frequently used supplier of computer
navigation equipment but supplies no prostheses. The
annual cost was calculated based on a five-year usage
period for the equipment; the additional cost per depart-
ment per year was then calculated to NOK 216,500. The
cost of disposable equipment was additional. The annual
cost was divided by the number of patients operated on
at the hospital, in order to find the added cost per oper-
ation. Frequent upgrades and new technology may be
envisaged to drive the costs up. Consequently, we also
looked at the outcome in a scenario where prices were
increased by 100%, i.e. to NOK 433,000. The cost per
operation, without the use of computer navigation, was
based on DRG rate 209A (NOK 146,135) for primary
prostheses and 209B (NOK 192,418) for revision pros-
theses in 2011, which gives the average total cost ofthese operations at Norwegian hospitals [28]. We
expected the hospitalisation periods and staff require-
ments to be equal with computer navigation and the
traditional method.
Analysis
The ICER (”incremental cost-effectiveness ratio”) was
found by dividing the difference between total accumu-
lated costs (including the cost of future knee replacement
revisions) by the difference in total quality-adjusted life
years gained for each of the surgical methods. As in ac-
cordance with the guidance provided by the UK National
Institute for Clinical Excellence (NICE), our calculations
did not include loss of productivity [29]. In other words,
our strategy was to find parameter values based on today’s
literature and data that would produce as true a picture
as possible (Table 1). Each cycle (each year) of the
model was analysed with respect to accumulated costs
and quality-adjusted life years. Finally, the total cost and
total number of quality-adjusted life years were analysed
for each of the surgical methods (computer navigation
and conventional arthroplasty) when all patients included
in the model had reached the health state of dead. We
used sensitivity analyses to test the stability of the con-
clusions by varying the parameter values above a certain
interval, to see what effect they had on the outcome
(ICER). A two-way sensitivity analysis was used for the
two age cohorts in order to investigate the relationship
between patient volume, the probability of revision, and
the cost effectiveness of computer assisted surgery in
Norway (Table D in Additional file 1).
Ethics
The Norwegian Arthroplasty Register has permission
from the Norwegian Data Inspectorate to collect patient
data, based on obtaining written consent from patients
(last issued May 24, 2004; reference number 2003/58-3).
Results
In the course of 20 years (20 cycles in the Markov
model) a 60-year-old is expected to gain 7.44 quality-
adjusted life years, while a 75-year-old would gain 5.46
quality-adjusted life years. The cost of these quality-
adjusted life years depends on the patient volume and
whether any revision surgery is required. At the outset,
we assumed that the probability of revision is identical
for conventional atrhroplasty and computer assisted
surgery. At a volume of 250 prostheses per year, the cost
of conventional arthroplasty in 60-year-olds is NOK
340,606; with computer assisted surgery the cost is
NOK 341,558. For 75-year-olds, the cost of conven-
tional arthroplasty is NOK 335,994 while the cost of
computer assisted surgery is NOK 336,946. For conven-
tional arthroplasty, this amounts to a cost per quality-
Number of patients per year Number of patients per year
a b
Figure 3 The results of the sensitivity analysis for patient volumes in a) cohort 1 (age 60) and b) cohort 2 (age 75). The blue cross-
hatched areas show when computer navigation is cost effective. The area between the threshold (black line) and the blue cross-hatched area
shows when the cost of computer navigation does not exceed the healthcare sector’s willingness to pay per QALY.
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computer assisted surgery, the corresponding figure is
NOK 45,890, which is a difference of NOK 128. For
75-year-olds the cost per quality-adjusted life year
undergoing conventional arthroplasty is NOK 61,537;85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
25/60y 25/75y 250/60y 250/75y
CAS TKA
Figure 4 The dark blue areas of the columns illustrate the
improvement in 10-year Kaplan-Meier implant survival which is
required for computer navigation not to exceed the healthcare
sector’s NOK 500,000 threshold. For example, the column to the
far left (25/60 years of age) illustrates this for a hospital with a low
patient volume (25 knee replacements per year) and a younger
population (age 60).for computer assisted surgery, the corresponding figure
is NOK 61,712, which is a difference of NOK 175 per
quality-adjusted life year. If we make a similar calcula-
tion for a volume of 25 prostheses per year, we find that
the added cost of computer navigation amounts to
NOK 1,037 per quality-adjusted life year for 60-year
-olds and NOK 1,414 for 75-year-olds. These values
represent a base case before we take account of changes
to the probability of revision following the introduction
of the new method and how the result is impacted by
increased costs.
Figures 3a and b show that when the probabilities of
revision are equal, the cost per quality-adjusted life year
is higher for computer assisted knee replacement sur-
gery than for conventional knee replacements, and there
are no savings to be made. Should the probability of re-
vision be improved, the number of quality-adjusted life
years will increase and therefore reduce the cost per
quality-adjusted life year. If the improvement is consid-
erable, savings may be made. Given that the health care
sector’s maximum threshold value for acceptable added
cost (ICER) is NOK 500,000 per quality-adjusted life
year gained, we find in both cohorts that a small im-
provement of implant survival is required to get below
the threshold. At low patient volumes and a low impact
on the probability of revision, we will risk surpassing the
threshold value (Tables C and D in Additional file 1).
In order to get below the threshold of the sector’s will-
ingness to pay, the probability of revision will have to fall
by at least 7.5% (of 10.2%) for cohort 1 at a volume of 25
knee replacements per year, and by at least 1% at a vol-
ume of 250 knee replacements per year. For cohort 2
the probability of revision needs to fall by at least 7%
(of 4.9%) at a volume of 25 prostheses per year and by
Gøthesen et al. BMC Musculoskeletal Disorders 2013, 14:202 Page 7 of 9
http://www.biomedcentral.com/1471-2474/14/202at least 1% at a volume of 250 prostheses per year. If
we convert this information, we find that the improve-
ment needs to increase the 10-year implant survival in
cohort 1 from 89.8% to 90.6% at a volume of 25 pros-
theses per year, and from 89.8 to 89.9% at 250 pros-
theses per year. In cohort 2 implant survival needs to
improve from 95.1% to 95.4% at a volume of 25 pros-
theses per year and from 95.10% to 95.14% at a volume
of 250 prostheses per year (Figure 4). The probability
of getting below the ICER threshold is virtually the
same for the older cohort as for the younger cohort.
Doubling the cost had little impact on the probability
of getting below the threshold value of NOK 500,000 at
high patient volumes. For low patient volumes, doubling
the cost would require further improvement of implant
survival (for cohort 1: from 90.6% to 91.1% and for co-
hort 2: from 95.4% to 95.7%), to get below the healthcare
sector’s threshold value of NOK 500,000 per quality-
adjusted life year (Table C in Additional file 1: Figures
5a, 5b, 6a and 6b in Additional file 1).
A sensitivity analysis of variations between 1% and 10%
to the discount rate showed no impact on the results.
Discussion
The model suggests that computer navigation may be
an alternative to today’s conventional total knee re-
placement, provided there is proven reduction in the
probability of revision, and provided the price of navi-
gation equipment does not rise. To date, no studies
have documented that computer navigation causes such
reduction. In order to get below the healthcare sector’s
threshold value for cost added per quality-adjusted life
year gained, the probability of revision needs to be re-
duced by somewhere between 0.8% and 13.0%, depend-
ing on patient volume and the cost of the computer
navigation equipment. It is clear that patient volume,
not surprisingly, impacts significantly on the cost ef-
fectiveness of computer navigation. At high patient vol-
umes the improvement required is less than at low
patient volumes. Age appears not to influence the prob-
ability of getting below the threshold value to any great
extent, but there is a minor trend indicating that the
probability is greatest in the older cohort, particularly
at low patient volumes.
The information provided by this analysis is valuable
to hospitals and health politicians focusing on areas that
provide as much health as possible for the money.
Moreover, the model may be transferred to other high-
cost surgical procedures, particularly within areas cov-
ered by quality registers that are in a position to provide
much valuable information. Ever-increasing healthcare
costs make it increasingly important to evaluate the
usefulness of new technology. Two of the authors re-
cently published an analysis of the cost effectiveness ofcomputer navigation and knee replacement surgery in
the US [30]. They investigated the impact of patient vol-
ume on cost effectiveness. It was found that it would be
more difficult to achieve cost effectiveness at low pa-
tient volumes than at high patient volumes. Norwegian
circumstances are significantly different from American
circumstances in a number of ways. Our costings are
based on prices in the Norwegian market and to the
Norwegian Health Service, which are different from
those available in the USA. Also, the implant survival
used in this analysis is based on figures obtained from
the Norwegian Arthroplasty Register.Strengths and weaknesses
An important strength of this analysis is the use of im-
plant survival data from the Norwegian Arthroplasty
Register, which includes prospective data about more
than 26,000 total knee replacements [31]. This data
strengthens the analysis in that it allows for the prob-
ability of revision to be specified year by year, based on
results reported by a number of different surgeons at
different hospitals in a single country. By combining this
data with cost and mortality data from the same country,
the analysis becomes relevant at number of levels within
the Norwegian Health Service. However, the register holds
data only for the last 11 years (at the time of analysis),
which meant we had to estimate the implant survival
rate for all earlier years.
The model does not take account of the cost of in-
creased operation time. We know that the operation
time for bicompartmental knee prostheses in Norway
has fallen from an average of 109 minutes in 1994 to 96
minutes in 2008. When using computer navigation, the
operation time rose in the period 2005–2008 to 107 mi-
nutes in 2008, probably due to a rise in the spread of
such navigation equipment combined with limited ex-
perience of its use [32]. For beginners, the procedure
will be time-consuming, but given experience and tech-
nology improvements the operation time is likely to be
considerably reduced. Furthermore, the cost of longer
operation times will depend on the organisation’s ability
to make alternative use of the time saved. The model
may therefore over estimate or under estimate the real
cost of the procedures.
Utility values are extrapolated in a number of different
ways, which means there may be a number of different
utility values for a given state [33]. We have looked at
values within prosthesis surgery and compared two groups
which at first appear identical. However, the values quoted
in the literature differ considerably for the same states.
There is a risk of over estimating or under estimating the
values and this may impact on the result, but because we
limit our analysis to arthroplasty and compare primary
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erroneous estimates will be kept to a minimum.
Another limitation of the analysis is the estimate of
probability of changing health states. Data used to deter-
mine the yearly probability of revision include patients
that had their prosthesis implanted many years ago, with-
out allowing for later developments with respect to tech-
nique, material and design. The estimated probabilities
may therefore differ from the real values for today’s knee
replacement patients in Norway, and also may differ
between countries. The threshold to perform a revision
may be affected by socio-economical state, patient co-
morbidities and surgeon’s experience, which may differ
between countries and regions Furthermore, the analysis
does not take account of re-revisions. The probability of
re-revisions for reasons of aseptic loosening or prosthesis
infection may not be the same in both groups, and this
may have impacted on the result of the analysis. The fre-
quency of complications such as thromboembolism, infec-
tion and postoperative confusion, may also be different.
Furthermore, earlier studies based on Norwegian register
data have indicated an increased risk of aseptic loosening
and infection with longer operation times [34]. If com-
puter navigation leads to longer operation times, this may
impact negatively on the outcomes for this procedure.
We found that high volume centres are more likely to
achieve cost-effectiveness. On the other hand, small vol-
ume centres might imply that the knee surgeons have a
low volume and thereby less experience. Thus, the need
of a more precise technology might be greater in a small
volume centre. This aspect must be evaluated when con-
sidering investments in this new technology.
Further studies, including register studies and ran-
domised studies with long-term follow-ups, are neces-
sary to prove any differences in outcomes between the
two surgical techniques. In particular, any impact that
computer navigation may have on implant survival will
be crucial. It is of considerable concern that there may
even be an increased risk of revision in the short term,
when computer is being used [32].
Conclusions
The healthcare sector’s willingness to pay may be
expected to cover the added cost of computer assisted
knee replacement surgery provided the patient volume is
large and there is positive impact on implant survival.
The probability of getting below the financial threshold
for added cost per quality-adjusted life year gained, is
falling at rate with falling patient volumes and falling
survival rates. The patients’ age has little impact. The
new technique should be carefully tested in a group of
hospitals with different age groups and patient volume
to evaluate the long term outcome. This model estimates
required survival rates to achieve cost-effectiveness withCAS. Until such results are achieved and reported from
clinical trials, we suggest deferral of extended invest-
ments in computer navigation technology.
Additional file
Additional file 1: Appendix.
Competing interests
Conflicts of interest declared: The project’s main sponsor is the Research
Council of Norway and Øystein Gøthesen has had a PhD grant.
Authors' contributions
JS and ØG performed the statistical analysis and drafted the manuscript. OF,
LH, JEA and HM participated in its design, coordination and interpretation of
the results, and helped to draft the manuscript. All authors read and
approved the final manuscript.
Author details
1Department of Orthopaedic Surgery, Haugesund Hospital, Karmsundsgate
120, 5528, Haugesund, Norway. 2Department of Orthopaedic Surgery, New
York University (NYU) Hospital for Joint Diseases, 301 East 17th Street; Suite
1616, New York, NY 10003, USA. 3The Norwegian Arthroplasty Register,
Department of Orthopedic Surgery, Haukeland University Hospital, Jonas Lies
vei 65, 5053, Bergen, Norway. 4Department of Surgical Sciences, University of
Bergen, 5021, Bergen, Norway. 5Stein Rokkan Centre for Social Studies, Uni
Research, University of Bergen, 5021, Bergen, Norway. 6Department of
Orthopaedic Surgery, Massachusetts General Hospital, 55 Fruit Street, Boston,
MA 02114, USA.
Received: 7 September 2012 Accepted: 29 May 2013
Published: 6 July 2013
References
1. Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY: Health-related quality
of life in total hip and total knee arthroplasty. A qualitative and systematic
review of the literature. J Bone Joint Surg Am 2004, 86-A(5):963–974.
2. Furnes O, Espehaug B, Lie SA, Vollset SE, Engesaeter LB, Havelin LI: Early
failures among 7,174 primary total knee replacements: a follow-up study
from the Norwegian Arthroplasty Register 1994–2000. Acta Orthop Scand
2002, 73(2):117–129.
3. Saleh KJ, Celebrezze M, Kassim R, Dykes DC, Gioe TJ, Callaghan JJ, et al:
Functional outcome after revision hip arthroplasty: a metaanalysis.
Clin Orthop Relat Res 2003, 416:254–264.
4. Furnes O, Havelin LI, Espehaug B, Steindal K, Soeraas TE: The Norwegian
arthroplasty register. Annual report 2009 2009:62.
5. Jeffery RS, Morris RW, Denham RA: Coronal alignment after total knee
replacement. J Bone Joint Surg Br 1991, 73(5):709–714.
6. Ritter MA, Faris PM, Keating EM, Meding JB: Postoperative alignment of
total knee replacement. Its effect on survival. Clin Orthop Relat Res 1994,
299:153–156.
7. Bauwens K, Matthes G, Wich M, Gebhard F, Hanson B, Ekkernkamp A, et al:
Navigated total knee replacement. A meta-analysis. J Bone Joint Surg Am
2007, 89(2):261–269.
8. Longstaff LM, Sloan K, Stamp N, Scaddan M, Beaver R: Good alignment
after total knee arthroplasty leads to faster rehabilitation and better
function. J Arthroplasty 2009, 24(4):570–578.
9. Graff BA, Thurmer H, Soreide O, Norderhaug IN: When new methods are
about to be introduced. Tidsskr Nor Legeforen 2008, 14(128(4)):472.
10. Furnes O: Hip prostheses and cements. Tidsskr Nor Legeforen 2004,
23(124(18)):2395.
11. Saelensminde K: IS-1435: Helseeffekter i samfunnsøkonomiske analyser.
2007:26. Published by Sosial- og helsedirektoratet, Helseøkonomi og finansiering,
Pb. 7000 St Olavs plass, 0130 Oslo http://www.kvalitetogprioritering.no/saker/_
attachment/12363?_download=true&_ts=118895adfb8.
12. Veileder i samfunnsøkonomiske analyser: 2005:35. Published by
Finansdepartementet, Akersgata 40, Postboks 8008 Dep, 0030 Oslo. http://
www.regjeringen.no/upload/kilde/fin/reg/2005/0029/ddd/pdfv/266324-
veileder_i_samfunnsok_analyse_trykket.pdf.
Gøthesen et al. BMC Musculoskeletal Disorders 2013, 14:202 Page 9 of 9
http://www.biomedcentral.com/1471-2474/14/20213. Buechel FF Sr: Long-term followup after mobile-bearing total knee
replacement. Clin Orthop Relat Res 2002, 404:40–50.
14. Gill GS, Joshi AB, Mills DM: Total condylar knee arthroplasty. 16- to
21-year results. Clin Orthop Relat Res 1999, 367:210–215.
15. Lidgren L, Knutson K, Robertsson O: The Swedish knee arthroplasty
register. Annual report 2004 2004:4.
16. Ranawat CS, Flynn WF Jr, Saddler S, Hansraj KK, Maynard MJ: Long-term
results of the total condylar knee arthroplasty. A 15-year survivorship
study. Clin Orthop Relat Res 1993, 286:94–102.
17. Furnes O, Espehaug B, Lie SA, Vollset SE, Engesaeter LB, Havelin LI: Failure
mechanisms after unicompartmental and tricompartmental primary knee
replacement with cement. J Bone Joint Surg Am 2007, 89(3):519–525.
18. Havelin LI, Engesaeter LB, Espehaug B, Furnes O, Lie SA, Vollset SE: The
Norwegian Arthroplasty Register: 11 years and 73.000 arthroplasties.
Acta Orthop Scand 2000, 71(4):337–353.
19. Espehaug B, Furnes O, Havelin LI, Engesaeter LB, Vollset SE, Kindseth O:
Registration completeness in the Norwegian Arthroplasty Register.
Acta Orthop 2006, 77(1):49–56.
20. Life tables Norway 2005, Statistisk sentralbyrå, Statistics Norway. P.O. Box
8131 Dep.,NO-0033,Oslo,NORWAY. http://www.ssb.no/a/english/kortnavn/
dode_en/arkiv/tab-2006-04-27-05-en.html.
21. Mahomed NN, Barrett J, Katz JN, Baron JA, Wright J, Losina E: Epidemiology
of total knee replacement in the United States Medicare population.
J Bone Joint Surg Am 2005, 87(6):1222–1228.
22. Heck DA, Robinson RL, Partridge CM, Lubitz RM, Freund DA: Patient
outcomes after knee replacement. Clin Orthop Relat Res 1998, 356:93–110.
23. Karrholm J, Garellick G, Rogmark C, Herberts P: Swedish hip arthroplasty
register. Annual report 2007 2007:67–69.
24. Fryback DG, Dasbach EJ, Klein R, Klein BE, Dorn N, Peterson K, et al: The
Beaver Dam health outcomes study; initial catalog of health-state
factors. Med Decis Making 1993, 13:89–102.
25. Hunink MG, Glasziou PP, Siegel JE, Weeks JC, Pliskin JS, Elstein AS: Decision
making in health and medicine. The Edinburgh Building, Shaftesbury Road,
Cambridge CB2 8RU, UK: Cambridge university press; 2001.
26. Anderson KC, Buehler KC, Markel DC: Computer assisted navigation in
total knee arthroplasty: comparison with conventional methods.
J Arthroplasty 2005, 20(7 Suppl 3):132–138.
27. Bolognesi M, Hofmann A: Computer navigation versus standard
instrumentation for TKA: a single-surgeon experience. Clin Orthop Relat
Res 2005, 440:162–169.
28. Informasjonshefte: Innsatsstyrt finansiering 2006. Helse- og
omsorgsdepartementet 2006. Public information, ISBN: I-3/2006NB.
Fagbokforlaget, Kanalveien 51, 5068 Bergen, Norway.
29. Guide to the methods of technology appraisal. National Health Services,
National Institute for Health and Clinical Excellence 2008. Paragraph 5.2.10.
www.nice.org.uk N1618 1P June 2008, ISBN: 1-84629-741-9.
30. Slover JD, Tosteson AN, Bozic KJ, Rubash HE, Malchau H: Impact of hospital
volume on the economic value of computer navigation for total knee
replacement. J Bone Joint Surg Am 2008, 90(7):1492–1500.
31. Furnes O, Havelin LI, Espehaug B, Engesaeter LB, Lie SA, Vollset SE: Det
norske leddregisteret - 15 nyttige år for pasientene and for
helsevesenet. Tidsskr Nor Legeforen 2003, 123:1367.
32. Gothesen O, Espehaug B, Petursson G, Havelin LI, Furnes O: Short term
outcome of 1465 computer navigated primary total knee replacements.
A report from the Norwegian Arthroplasty Register. Acta Orthop Scand
2011, 82(3):293–300.
33. Arnesen T, Trommald M: Are QALYs based on time trade-off comparable?–A
systematic review of TTO methodologies. Health Econ 2005, 14(1):39–53.
34. Smabrekke A, Espehaug B, Havelin LI, Furnes O: Operating time and
survival of primary total hip replacements: an analysis of 31.745 primary
cemented and uncemented total hip replacements from local hospitals
reported to the Norwegian Arthroplasty Register 1987–2001. Acta Orthop
Scand 2004, 75(5):524–532.
doi:10.1186/1471-2474-14-202
Cite this article as: Gøthesen et al.: An economic model to evaluate
cost-effectiveness of computer assisted knee replacement surgery in
Norway. BMC Musculoskeletal Disorders 2013 14:202.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
